MedPath
NMPA Approval

Recombinant Human Papillomavirus 9-Valent (Types 6,11,16,18,31,33,45,52,58)Vaccine

国药准字SJ20180008

January 5, 2024

S20180008

Drug Information

九价人乳头瘤病毒疫苗(酿酒酵母)

佳达修9

注射剂

0.5mL/支(预填充注射器)

生物制品

January 5, 2024

March 30, 2028

Company Information

Applicant Company

Merck, Inc.

126 East Lincoln Ave, P.O. Box 2000, Rahway, NJ07065, US

Manufacturing Company

msd ireland; merck sharp & dohme llc

Dublin Road,Carlow Co., Carlow, Ireland; 770 Sumneytown Pike, West Point, Pennsylvania 19486, USA

© Copyright 2025. All Rights Reserved by MedPath